Nigral degeneration in a case of amyotrophic lateral sclerosis: Evidence of Lewy body-like and skein-like inclusions in the pigmented neurons

Clinical Neuropathology

Volumn 18, Issue 6, 1999, Pages 293-300

  Su, M ^a   Yoshida, Y ^a,b   Ishiguro, H ^a   Hirota, K ^a  

^a AKITA RED CROSS HOSPITAL   (Japan)

^b RESEARCH INSTITUTE FOR BRAIN AND BLOOD VESSELS AKITA   (Japan)

Author keywords

Amyotrophic lateral sclerosis; Inclusion body; Nigral degeneration; Ubiquitin; Ultrastructure

Indexed keywords

UBIQUITIN;

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CASE REPORT; CELL INCLUSION; GLIOSIS; HUMAN; IMMUNOHISTOCHEMISTRY; LEWY BODY; MALE; MOTONEURON; NERVE DEGENERATION; NEUROPATHOLOGY; PRIORITY JOURNAL; SUBSTANTIA NIGRA;

AMYOTROPHIC LATERAL SCLEROSIS; HUMANS; IMMUNOHISTOCHEMISTRY; INCLUSION BODIES; LEWY BODIES; MALE; MICROSCOPY, ELECTRON; MIDDLE AGED; NERVE DEGENERATION; NEURONS; PIGMENTATION; SUBSTANTIA NIGRA;

EID: 0032719271     PISSN: 07225091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Bergmann M, Kuchelmeister K, Migheli A, Schiffer D, Gullotta F 1993 Motor neuron disease with pallido-luysio-nigral atrophy. Acta Neuropathol 86: 105-108
2. Duffy PE, Tennyson VM 1965 Phase and electron microscopic observations of Lewy bodies and melanin granules in the substantia nigra and locus ceruleus in Parkinson's disease. J Neuropathol Exp Neurol 24: 398-414
3. Hasegawa K, Kowa H, Yagishita S 1992 Extrapyramidal system involvement in motor neuron disease. J Neurol Sci 108: 137-148
4. Hayashi Y, Kakita A, Yamada M, Egawa S, Oyanagi S, Naito H, Tsuji S, Takahashi H 1998 Hereditary dentatorubral-pallido-luysian atrophy: ubiquitinated filamentous inclusions in the cerebellar dentale nucleus neurons. Acta Neuropathol 95: 479-482
5. Horoupian DS, Thal L Katzman R, Terry RD, Davies P, Hirano A, DeTeresa R, Fuld PA, Petito C, Blass J, Ellis JM 1984 Dementia and motor neuron disease: morphometric, biochemical and Golgi studies. Ann Neurol 16: 305-313
6. Ince PG, Lowe J, Shaw PJ 1998 Amyotrophic lateral sclerosis: current issues in classification, pathogenesis and molecular pathology. Neuropathol Appl Neu robiol 24: 104-117
7. Itoh H, Nakamura S, Akigachi I, Yamao S, Kameyama M 1987 Levodopa therapy for a patient with ALS-dementia complex. Clin Neurol (Tokyo) 27: 1145-1149
8. Jacobs L, Bozian D, Heffner Jr RR, Barron SA 1981 An eye movement disorder in amyotrophic lateral sclerosis. Neurology 31: 1282-1287
9. Kato S, Oda M, Murahashi M, Suda N 1995 Motor neuron disease with involvement of the pallido-luysio-nigral system and mesencephalic tegmentum. Clin Neuropathol 14: 241-244
10. Kato S, Oda M, Tanabe H 1993 Diminution of dopaminergic neurons in the substantia nigra of sporadic amyotrophic lateral sclerosis. Neuropathol Appl Neurobiol 19: 300-304
11. Kawashima T, Kikuchi H, Takita M, Doh-ura K, Ogomori K, Oda M, Iwaki T 1998 Skein-like inclusions in the neostriatum from a case of amyotrophic lateral sclerosis with dementia. Acta Neuropathol 96: 541-545
12. Kuroda S, Kuyama K, Morioka E, Ohtsuki S, Nanba R 1986 Sporadic amyotrophic lateral sclerosis with intracytoplasmic eosinophilic inclusions, a case closely akin to familial ALS. Neurol Med (Tokyo) 24: 31-37
13. Leigh PN, Whitwell H, Garofalo O, Buller J, Swash M, Martin JE, Gallo J-M, Weller RO, Anderton BH 1991 Ubiquitin-immunoreactive intraneuronal inclusions in amyotrophic lateral sclerosis. Brain 114: 775-788
14. Lowe J 1994 New pathological findings in amyotrophic lateral sclerosis. J Neurol Sci 124 (Suppl): 38-51
15. Lowe J, Lennox G, Leigh PN 1997 Disorders of movement and system degenerations. In: Graham DI, Lantos PL (eds) Greenfield's Neuropathology (Vol II, 6th ed). Edward Arnold, London, pp 281-366
16. Mitsayama Y 1984 Presenile dementia with motor neuron disease in Japan: clinico-pathological review of 26 cases. J Neurol Neurosurg Psychiatry 47: 953-959
17. Murayama S, Mori H, Ihara Y, Bouldin TW, Suzaki K, Tomonaga M 1990 Immunocytochemical and ultrastructural studies of lower motor neurons in amyotrophic lateral sclerosis. Ann Neurol 27: 137-148
18. Neary D, Snowden JS, Mann DMA, Northen B, Goulding PJ, Macdermott N 1990 Frontal lobe dementia and motor neuron disease. J Neurol Neurosurg Psychiatry 53: 23-32
19. Okuda B, Yamamoto T, Yamasaki M, Maya K, Imai T1992 Motor neuron disease with slow eye movements and vertical gaze palsy. Acta Neurol Scand 85: 71-76
20. Ono S, Inoue K, Mannen T, Mitake S, Shirai T, Kanda F, Jinnai K, Takahashi K 1989 Intracytoplasmic inclusion bodies of the thalamus and the substantia nigra, and Marinesco bodies in myotonic dystrophy: a quantitative morphological study. Acta Neuropathol 77: 350-356
21. Schocket Jr SS, Wyatt RB, McCormick WF 1970 Intracytoplasmic acidophilic granules in the substantia nigra: a light- and electron-microscopic study. Arch Neurol 22: 550-555
22. Sourkes TL 1989 Disorders of the basal ganglia. In: Siegel GJ, Agranoff BW, Albers R W, Molinoff PB (eds) Basic Neurochemistry: Molecular, Cellular, and Medical Aspects (4th ed). Raven Press, New York, pp 811-825
23. Suenaga T, Matsushima H, Nakamura S, Akiguchi I, Kimura J 1993 Ubiquitin-immunoreactive inclusions in anterior horn cells and hypoglossal neurons in a case with Joseph's disease. Acta Neuropathol 85: 341-344
24. Tranchant C, Dugay MH, Mohr M, Wasser P, Warter JM 1992 Familial motor neuron disease with Lewy body-like inclusions in the substantia nigra, the subthalamic nucleus, and the globus pallidus. J Neurol Sci 108: 18-23
25. Wakabayashi K, Matsumoto K, Takayama K, Yoshimoto M, Takahashi H 1997 NACP, a presynaptic protein, immunoreactivity in Lewy bodies in Parkinson's disease. Neurosci Lett 239: 45-48
26. Yoshida M, Murakami N, Hashizume Y, Takahashi A 1992 A clinicopathological study on 13 cases of motor neuron disease with dementia. Clin Neurol (Tokyo) 32: 1193-1202